| Variables | r | P |
| FPG: Fasting plasma glucose; PPG: Postprandial plasma glucose; HbA1c: Glycated hemoglobin; BMI: Body mass index; BUN: Blood urea nitrogen; eGFR: Estimated glomerular filtration rate; MBG: Mean blood glucose; SD: Standard deviation; CV: Coefficient of variance; ΔBG: The difference between the highest and lowest blood glucose; MAGE: Mean amplitude of glycemic excursions; %TIR: The percentage of time in range. | ||
| Baseline variables | ||
| Gender | -0.015 | 0.861 |
| Age | -0.091 | 0.272 |
| BMI | -0.015 | 0.865 |
| Microvascular complications | 0.074 | 0.376 |
| Combined hypertension | -0.197 | 0.017(1) |
| Duration of hypertension | -0.166 | 0.050 |
| Insulin secretagogues | -0.127 | 0.125 |
| Sulfonylureas | -0.057 | 0.494 |
| Glinides | -0.116 | 0.164 |
| Metformin | -0.002 | 0.983 |
| Glitazones | -0.145 | 0.080 |
| α-glucosidase inhibitors | -0.017 | 0.392 |
| Sodium-dependent glucose transporters 2 inhibitors | -0.020 | 0.806 |
| Glucagon like peptide-1 receptor agonists | 0.084 | 0.310 |
| Dipeptidy1 peptidase-4 inhibitors | -0.002 | 0.982 |
| Insulin treatment | 0.189 | 0.022(1) |
| FPG | -0.321 | < 0.001(3) |
| PPG | -0.189 | 0.030(1) |
| Fasting plasma insulin | -0.123 | 0.157 |
| Postprandial plasma insulin | -0.010 | 0.908 |
| Fasting plasma C peptide | -0.234 | 0.006(2) |
| Postprandial plasma C peptide | -0.113 | 0.195 |
| HbA1c | -0.056 | 0.532 |
| BUN | -0.202 | 0.017(1) |
| eGFR | 0.009 | 0.916 |
| CGM parameters | ||
| MBG | -0.382 | < 0.001(3) |
| SD | 0.236 | 0.004(2) |
| CV | 0.500 | < 0.001(3) |
| ΔBG | 0.355 | < 0.001(3) |
| MAGE | 0.169 | 0.042(1) |
| %TIR (mmol/L) | ||
| 3.9-7.8 | 0.263 | 0.001(2) |
| > 7.8 | -0.336 | < 0.001(3) |
| 3.9-10.0 | 0.095 | 0.252 |
| > 10.0 | -0.196 | 0.017(1) |
